Effects of carbon-coated coronary stents on the markers of inflammation, thrombin generation and platelet and endothelial activation

Italian Heart Journal

Volumn 4, Issue 1, 2003, Pages 23-28

  Tomai, Fabrizio ^c   Ghini, Anna S ^c   Ferri, Claudio ^a   Desideri, Giovambattista ^a   Versaci, Francesco ^c   Gaspardone, Achille ^c   Altamura, Luca ^c   Magliano, Giulia ^c   Crea, Filippo ^b   Chiariello, Luigi ^c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Coagulation; Coronary stent; Platelets; Thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CARBON; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IOVERSOL; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TICLOPIDINE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL WALL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; ENDOTHELIUM CELL; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; INFLAMMATION; MALE; MATERIAL COATING; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; THROMBOCYTE ACTIVATION;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CARBON; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STENTS; THROMBIN; TREATMENT OUTCOME;

EID: 0038287886     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gawaz M, Neumann FJ, Ott I, May A, Schomig A. Platelet activation and coronary stent implantation. Effect of antithrombotic therapy. Circulation 1996; 94: 279-85.
2. Gaspardone A, Crea F, Versaci F, et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 1998; 82: 515-8.
3. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffè PA. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 2000; 85: 92-5.
4. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, et al. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000; 21: 1152-8.
5. Walter DH, Fichtlscherer S, Britten MB, et al. Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol 2001; 38: 2006-12.
6. Aebischer P, Gooddard MB, Sasken HF, Hunter TJ, Galletti PM. Tissue reaction to fabrics coated with turbostatic carbon: subcutaneous versus vascular implants. Biomaterials 1998; 9: 80-5.
7. Monnink SH, van Boven AJ, Peels HO, et al. Silicon carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation. J Investig Med 1999; 47: 304-10.
8. Bartorelli AL, Virmani R, Antoniucci D. The Sorin Carbostent. In: Serruys PW, Kutryk MJB, eds. Handbook of coronary stent. 3rd edition. London: Martin Dunitz, 2000: 77-186.
9. Rzany A, Schaldach M. Smart material silicon carbide: reduced activation of cells and proteins on a-SiC:H coated stainless steel. Prog Biomed Res 2001; 6: 182-94.
10. Van Oeveren W. Polyethylene and silicon carbide coated steel promote less complement activation and platelet or leukocyte adhesion than medical steel and silicon rubber material. Prog Biomed Res 2001; 6: 195-201.
11. Paccagnella C, Majni G, Ottaviani G, Arru P, Santi M, Vallana F. Properties of a new carbon film for biomedical applications. Int J Artif Organs 1986; 9: 127-30.
12. Baim DS, Cutlip DE, Midei M, et al, for the ASCENT Investigators (ACS MultiLink Stent Clinical Equivalence in De Novo Lesions Trial). Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 2001; 87: 157-62.
13. Foley DP, Kererakes D, te Riele JA, et al, for the US and European Duet Investigators. Acute and 6-month clinical and angiographic outcome after implantation of the ACS Duet stent for single-vessel coronary artery disease: final results of the European and US ACS Multi-link Duet Registry. Catheter Cardiovasc Interv 2001; 54: 25-33.
14. Reiber JHC, von Land CD, Koning G, et al. Comparison of accuracy and precision of qualitative coronary arterial analysis between cinefilm and digital systems. In: Reiber JHC, Serruys PW, eds. Progress in quantitative coronary arteriography. Dordrecht: Kluwer Academic Publishers, 1994: 67-85.
15. Hyafner G, Endler T, Oppitz M. Effects of standardization with the new international reference preparation for proteins in human serum on method comparability and reference values. Clin Lab 1995; 41: 743-8.
16. von Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-46.
17. Serruys PW, Emanuelsson H, van der Giessen W, et al, on behalf of the Benestent-II Study Group. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation 1996; 93: 412-22.
18. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffrè PA. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997; 336: 817-22.
19. Antoniucci A, Bartorelli A, Valenti R, et al. Clinical and angiographic outcome after coronary arterial stenting with the Carbostent. Am J Cardiol 2000; 85: 821-5.
20. Bartorelli AL, Trabattoni A, Montorsi P, et al. Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study. Catheter Cardiovasc Interv 2002; 55: 150-6.
21. Pepys MB. C-reactive protein fifty years on. Lancet 1981; 1: 653-6.
22. Gabay C, Kushener I. Acute-phase proteins and other systemic responses to inflammation. N EngI J Med 1999; 340: 448-54.
23. Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F1+2 fragment and thrombin-antithrombin complex. Blood 1982; 59: 1086-97.
24. Strauss BH, Lau HK, Bowman KA, et al. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis. Circulation 1999; 100: 1616-22.
25. Pernerstorfer T, Stohlawetz P, Stummvoll G, et al. Low dose aspirin does not lower in vivo platelet activation in healthy smokers. Br J Haematol 1998; 103: 1229-31.
26. Inoue T, Sohma R, Miyazaky T, Iwasaki Y, Yaguchi I, Morooka S. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris. Am J Cardiol 2000; 86: 1057-62.
27. Ferri C, Desideri G, Valenti M, Bellini C, Santucci A, De Mattia G. Early up-regulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 1999; 34: 568-73.
28. Malik IS, Haskard DO. Soluble adhesion molecules in ischaemic heart disease. Eur Heart J 1999; 20: 990-1.
29. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99: 44-52.
30. Kastrati A, Mehilli J, Dirschinger J, et al. Intracoronary stenting and angiographic results. Strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001; 103: 2816-21.
31. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002; 105: 2974-80.
32. Morice MC, Serruys PW, Sousa JE, et al, for the RAVEL Study Group. A randomized comparison of a sirolimuseluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.